Alfieri Cardiology

Wilmington, Delaware 19803-3733

0 studies enrolling now · 8 studies all time

What they study most

Cardiac Disease, Cardiovascular Disease, Coronary Artery Disease, Essential Hypertension, Heart Failure, High Cardiovascular Risk, Iron-deficiency, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
• Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142 — Completed
• DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY — Completed
• DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early